SCHEMBL7493370

SCHEMBL7493370

CCOC(=O)c1ccc(N/C(=C2\C(=O)Nc3ccc(S(=O)(=O)Nc4ccccc4)cc32)c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
ALDH1A1 P00352 3/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NHERF1 O14745 1/20 0.51
SMN1; SMN2 Q16637 8/20 0.51
LMNA P02545 3/20 0.51
RXFP1 Q9HBX9 1/20 0.47
MGAT2 Q10469 3/20 0.47
BRD4 O60885 1/20 0.47
MGAT1 P26572 1/20 0.47
MGAT3 Q09327 1/20 0.47
MAPT P10636 1/20 0.47
TSHR P16473 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7493373 1.00 MEN1 (0.52) MEN1KMT2AALDH1A1HPGDALOX15
SCHEMBL7499109 0.88 MAPT (0.52) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL7499102 0.88 MAPT (0.52) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL7490795 0.87 MEN1 (0.56) MEN1KMT2AMAPK1HSD17B10SMN1; SMN2
SCHEMBL7485899 0.87 BRD4 (0.53) MEN1KMT2AMAPK1SMN1; SMN2LMNA
SCHEMBL7490799 0.87 MEN1 (0.56) MEN1KMT2AMAPK1HSD17B10SMN1; SMN2
SCHEMBL7485892 0.87 BRD4 (0.53) MEN1KMT2AMAPK1SMN1; SMN2LMNA
SCHEMBL7488835 0.87 MGAT2 (0.55) MEN1KMT2AMAPK1SMN1; SMN2MGAT2
SCHEMBL7497322 0.87 MGAT2 (0.55) MEN1KMT2AMAPK1SMN1; SMN2MGAT2
SCHEMBL7493713 0.86 BRD4 (0.55) MEN1KMT2AALDH1A1LMNAMGAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224169-A2 PRODUCTION OF 5-SUBSTITUTED INDOLINONES AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027080-A2 5-SUBSTITUTED INDOLINONES AND USE THEREOF AS KINASE AND CYCLIN/CDK COMPLEX INHIBITORS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed